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Abstract This paper briefly reviews available technolo-
gies for measuring or estimating patient skin dose in the
interventional fluoroscopic environment.
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Introduction
The substantial use of fluoroscopy to guide interventional
procedures began in the 1980s. By 1990, radiation-induced
skin injury became a concern. Deterministic effects were
reported; attention was focused on malfunctioning equip-
ment and high dose-rate techniques. By the mid 1990s the
most likely cause was seen to be multiple procedures and
long procedures conducted at normal dose rates.
Dosimetric information is helpful at multiple levels.
Physics acceptance testing and QA processes assure dose-
rate limits on clinical equipment. Real-time monitoring
allows the operating physician to appropriately balance the
expected clinical benefits and radiation risks of continuing
a procedure. Postprocedure doseanalysis provides valuable
feedback into both the quality improvement process and
the supervision of individual patients. These can be im-
portant either if a patent returns for a follow-up procedure
or for continuing management if the index procedure was
high-dose.
Indirect real-time dose monitoring
Indirect dose measurements yield a measure of dose at a
defined location either using a physical dose measurement
at a convenient point or by performing calculations based
on equipment operating parameters and system geometry.
Fluoroscopic time
Modern fluoroscopes still include a 5-minute timer.
Fluoroscopic time is the traditional metric used for clinical
radiationmanagement.Evenwithbetterinformationreadily
available from the X-ray system, fluoroscopic time (with or
withoutacountofthenumberofimagesorcineruns)isstill
the only dose metric routinely employed in many interven-
tional fluoroscopy laboratories.
The fluoroscopic timer provides an inadequate skin-dose
estimate in the interventional lab for several reasons. The
most obvious of these is the total lack of information
regarding fluoroscopic dose rate. In addition, fluorographic
contributionsareignored.Finally,noaccountistakenofthe
beam’s entrance ports.
Kerma area product (KAP), also known as dose area
product (DAP)
KAP is defined as the integral of air kerma across the X-ray
beam.Therefore,KAPincludesfieldnon-uniformityeffects,
such as anode-heel effect, and the use of semitransparent
beam-equalizing shutters (lung shutter). KAP meters use
large-area transmission ionization chambers placed between
the final collimator shutters and the patient.KAP can alsobe
calculated in real-time with an algorithm that uses the X-ray
generator settings combined with collimator data.
Thesame KAP is observed with large fields andlow skin
doses as with small fields and high skin doses. Clinically,
reasonable field size estimates can be made for many
procedures. This can be used to obtain an estimate of skin
dose. Even when applying a field size estimate, KAP
providesnoinformationregardingthespatialdistributionof
the entrance beam on the patient’s skin. It produces an
overestimate of the possibility of exceeding the determin-
istic threshold when there is significant beam movement
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Cumulative dose at the IEC reference point (Cdose)
The International Electrotechnical Commission’s (IEC)
standard 60601-2-43 [1] defines an interventional reference
point (IRP) at a location that is “representative” of the
patient’s skin. For typical isocentric interventional equip-
ment, the default IRP is located on the central axis of the X-
ray beam at 15 cm on the X-ray tube side of isocenter.
The cumulative air kerma (calibrated free in air) is
reported. Effects, such as backscatter, table-top attenuation,
and the conversion of air to tissue kerma need to be con-
sideredwhencomparinginstrumentreadingswithmeasure-
ments obtained on the patient using film or a TLD.
Dose at a reference point also provides no information
regarding the spatial distribution of the entrance beam over
the patient’s skin. Beam motion or variation in the location
of the central beam axis and field size will cause the dose at
a reference point to overestimate maximum skin dose.
Allowable uncertainties for KAP and Cdose are ±35%
(FDA) and ±50% (IEC). This broad tolerance range was set
after considering other major uncertainties in determining
actual skin dose and predicting biological response. Closer
tolerances canbemaintained bya calibration procedure[2].
FDA “10 R/minute” point
FDA regulations limit table-top exposure rate to 10 R/min.
Most C-arm andisocentric fluoroscopes will permit smaller
source-to-skin distances (SSD) than is possible in a GI
system. The FDA goes on to define its C-arm measurement
point as 30 cm in front of the image receptor for any
source-to-image-receptor distance (SID). Fluoroscopes
with SID tracking maintain the 10 R/min limit 30 cm in
front of the image receptor at any SID. Actual maximum
skin exposure rates delivered by these systems will greatly
exceed 10 R/min when operated at maximum SID. Figure 1
illustrates the relationships between the IEC and FDA
measurement points.
Comparison of real-time indirect methods
Most interventional fluoroscopes can provide readouts of
fluoroscopy time, KAP, and Cdose. The RAD-IR project
reported [3, 4] these data for a total of 2,142 non-cardiac
procedures (mostly in adults). PSD measurements were
obtained in a subset of 800 of these procedures. The
procedures studied differ substantially in how radiation is
used, both in terms of spatial distribution of the incident
radiation field and in the ratio between fluoroscopy and
fluorography. The relationship among fluoroscopy time,
DAP, cumulative dose at the reference point and peak skin
dose (PSD) is a function of the type of procedure.
There was poor correlation between fluoroscopic time
and the other metrics. There was reasonable correlation
between KAP or Cdose and PSD for all procedures. The
ratios PSD/Cdose and PSD/KAP differ from procedure to
procedure. Based on RAD-IR, it seems reasonable to use
either KAP or Cdose as a real-time indicator of the onset of
deterministicinjury.Thereisconsiderablepatient-to-patient
variability (Fig. 2). Other studies have shown similar
variability [5–7].Real-time PSDmeasurementis,therefore,
the preferred technology. Cdose usually overestimates PSD
by a factor that involves patient size, position, and beam
motion during the procedure. Its use provides a conserva-
tive clinical skin-dose management tool.
DICOM DOSE (dose reporting)
The DICOM-DOSE project is a joint effort of the IEC and
the DICOM Committee to improve accessibility to radia-
tion dose information. The necessary standards documents
are expected to be completed and published in early 2006.
DICOM-DOSE-compliant fluoroscopes will generate an
independent radiation dose structured report (RDSR)
describing each procedure. Data from an interventional
fluoroscope will include: beam geometry, KAP, Cdose,
number of images, irradiation time, etc. These data are
reported on a run-by-run basis (including fluoroscopic runs
where no images are saved). The RDSR will be transferred
to a repository (PACS, MIS, or stand-alone system) for
analysis and archiving.
Fig. 1 Dose reference points. The IEC reference point is defined
relative to the isocenter of the imaging system. It is independent of
SID. The FDA measurement point is defined relative to the image
receptor at any SID. This point moves away from the focal spot as
SID increases
137Real-time indirect skin-dose mapping
The PEMNET system
This is an example of an add-on device that provides real-
time display of dose information and a permanent dose
record. This instrument is electrically connected to the
fluoroscopy system to obtain information on system tech-
nique parameters. These data, combined with geometrical
and patient position information, are combined with calibra-
tiondataviaamicroprocessortoprovideadisplayandrecord
of dose rate and cumulative dose to the patient’s skin. This
system, however, does not differentiate the dose to different
locations on the skin. The use of the PEMNET system
(Clinical Microsystems, Arlington, Va.) for patient dose
monitoring has been described in a number of reports [8, 9].
The CareGraph system
This approach uses a mathematical model to combine data
from a KAP meter with geometrical information on patient
size and beam location. It provides a display of dose rate,
cumulative dose and a real-time graphical display of the
estimated dose distribution on the skin of the patient. The
software models the shape and location of the patient’ss k i n
as an array of 0.5×0.5 cm patches. Every 500 ms, the
softwarecalculatesthe doserateateachirradiatedskinpatch
and the total dose delivered to that patch over time. The
maximum doseatanypoint onthepatient’ssk inisca ll edth e
peak skin dose (PSD). A prototype has been described [10].
A commercial version was previously marketed as the
CareGraph System (Siemens Medical Solutions, Malvern,
Pa.). Figure 3 illustrates the CareGraph map and dosimetry
film obtained during a RF cardiac ablation.
An interventionalist can monitor the distribution of skin
dose during the procedure with a real-time skin dose map.
In many cases a slight modification of the position of the
X-ray beam on the patient’s skin can dramatically reduce
PSD. Final maps provide documentation for patient
Fig. 2 Peak skin dose (PSD). a PSD vs. fluoroscopy time. Note that
there is more than an order of magnitude variation in PSD for any
fluoroscopy time. b PSD vs. cumulative dose (Cdose). Variability is
reduced to about a factor of two
Fig. 3 Dose distributions from a dose mapping system (a) and from
radiographic film (b). Procedure is a RF cardiac catheter ablation
using 51 min of fluoroscopy. Both data sets were obtained
simultaneously. The value and location of PSD are displayed. The
open rectangle displays the current location and size of the X-ray
beam (courtesy of Peter Kwan, Ph.D.)
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part of a quality improvement program.
Direct real-time and non-real-time dose monitoring
A direct real-time probe placed at the location of PSD is the
ideal dose measuring method. This is seldom possible in a
clinical situation. Non-real-time film sheets or detector
arrays produce dose maps without a-priori assumptions
about beam position. Even though the dose maps are only
availableaftertheprocedure,theycanbeextremelyvaluable.
Dose maps can be used to establish the ratios PSD/KAP
and PSD/Cdose for classes of procedures performed at a
particular institution. Locally established ratios, and the
local variability of these ratios, can provide a better dose
management tool than the uncritical acceptance of ratios
obtained from other sources.
Real-time point dosimeters
There are several approaches to measuring dose during
fluoroscopic procedures using geometrically small radia-
tion detectors that provide immediate dose information via
an electronic display.They should be positioned, a priori, at
exactly the right location on the patient if they are to record
the PSD. These instruments can provide real-time feedback
to the physician during the procedure to optimize radiation
usage.
Non-real-time point dosimeters
Point dosimeters (e.g. TLD chips, doped aluminum oxide
chips; Landauer, Glenwood, Ill.) can be applied to the pa-
tient’s skin prior to a procedure and read after the procedure.
Read-out usually occurs hours to days after the procedure.
Point dosimeters provide an accurate measurement of actual
skin dose at the points that they are applied. This can be
usefulincircumstancessuchaswhenthelocationofthePSD
is known a priori or when accurate measurement of the dose
delivered to a critical tissue is needed, or to normalize
indirect dose mapping technologies. Dosimeter arrays can
provide a skin dose map (Fig. 4).
Film dosimetry
Patient dosimetry for diagnostic and interventional X-ray
procedures using various types of film has been described
by a number of investigators. Dosimetry using film has the
advantages of providing a detailed indication of the
location of the skin dose, providing quantitative dose
information with careful calibration and densitometry, and
being used with any X-ray system.
Certain conventional X-ray films have a working range
from 0.01 Gy to about 2 Gy. This is sufficient for many
procedures but too sensitive for complex interventional
procedures. Even in these cases, the film can demonstrate
the distribution of dose and qualitatively indicate those skin
locations where the dose exceeded the upper limit of the
useful range of the film sensitivity.
A version of a radiochromic dosimetry film (GAF
CHROMIC XR-type R; International Specialty Products,
Wayne, N.J.) is available for quantitative mapping of
patient skin dose during fluoroscopy. Its lower sensitivity
makes it suitable for higher-dose fluoroscopy procedures.
Radiochromic material changes color in proportion to dose.
Sheets can be visually inspected after the procedure and
quantitatively analyzed after digital scanning.
Fig. 4 TLD array (a) and an example (b) of the data reported for a
RF cardiac catheter ablation procedure. The grid is 4×4 cm. Isodose
curves are spaced 20 cGy apart. The PSD is between 100 and
120 cGy. (This is a different case from that illustrated in Fig. 3)
(supplied by K and S Associates, Nashville, Tenn.)
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Clinical fluoroscopic dosimetry is a component of good
patient management. Direct and indirect dose measure-
ments document the radiological footprint of a procedure.
As such, they provide useful information regarding the
possible occurrence of an acute injury. Given that many
patients require multiple procedures, this documentation
also aids in the planning of return visits. The nature of the
measuring tool and its required accuracy are procedure-
dependent. Simpler instrumentation is appropriate for
fluoroscopes used only for known low-dose procedures.
Advanced techniques using more extensive evaluation
tools are indicated for higher-dose procedures and suscep-
tible patients.
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